Bill Summary for S 730 (2019-2020)

Summary date: 

Jun 24 2020

Bill Information:

View NCGA Bill Details2019-2020 Session
Senate Bill 730 (Public) Filed Wednesday, May 13, 2020
AN ACT PROVIDING PATIENT VISITATION RIGHTS AND APPROPRIATING FUNDS TO THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, DIVISION OF HEALTH SERVICE REGULATION, TO DEVELOP AND DISSEMINATE TO HOSPITALS FREE INFORMATIONAL MATERIALS EXPLAINING THESE RIGHTS, AND TO APPROPRIATE FUNDS FROM THE CORONAVIRUS RELIEF FUND FOR THE NORTH CAROLINA POLICY COLLABORATORY TO CARRY OUT A STATEWIDE TESTING, TRACKING, AND TRACING INITIATIVE FOR COVID-19 RESEARCH AND BUSINESS REOPENING PURPOSES AND TO PROVIDE GRANTS TO BUSINESSES THAT CLOSED AS A RESULT OF THE COVID-19 PANDEMIC.
Intro. by Daniel, Perry, Krawiec.

View: All Summaries for BillTracking:

Bill summary

House committee substitute makes the following changes to the 4th edition.

Modifies proposed new GS 131E-79.3 to provide that a hospital must allow a support person of the patient's choice, who may or may not be the patient's surrogate decision-maker, to be present during the patient's stay unless an enumerated exception applies. Requires hospitals to have written policies and procedures on visitation and to inform patients and support persons of their visitation rights. No longer includes provisions about visitation of minor patients; immediate family members of adult patients; limitations on the termination, suspension, or waiver of visitation rights; authorization for hospitals to conduct health screenings; or posting of informational materials. Makes conforming changes to the proposed statute's title.

Adds the following provisions.

Directs the State Controller to transfer $10 million from the Coronavirus Relief Reserve to the Coronavirus Relief Fund (both established by SL 2020-4) for the 2019-20 fiscal year. Appropriates the transferred funds to the Office of State Management and Budget (OSBM) on a nonrecurring basis for the 2019-20 fiscal year to be allocated to UNC-Chapel Hill for the NC Policy Collaboratory (Collaboratory) to implement a statewide COVID-19 testing, tracking and tracing initiative for the reopening of businesses and the protection of public health. Requires the funds to be used for: (1) creating an internet-based portal for NC-based businesses with an interest in using testing, tracking, and tracing incentives to sign up as participants in the program; (2) selecting a geographically balanced representation of businesses based on the economic tier of the county of operation and the State's economic opportunity zones; (3) selecting a diverse sampling of businesses based on their sector; (4) selecting technologies to be deployed in businesses to carry out an effective testing, tracking, and tracing program; (5) collecting, synthesizing, visualizing, and reporting data to show the efficacy of public health best practices in conjunction with businesses remaining open; and (6) any other research or activity related to monitoring, assessing, or addressing the public health and economic impacts of COVID-19.

Requires the Collaboratory to report to the specified NCGA committee on the progress of the use of appropriated funds received by September 1, 2020. 

Provides that the specified provisions of GS Chapter 143 and GS Chapter 116 do not apply to the purchase of apparatus, supplies, material, or equipment with any of the funds appropriated by the act.

Restricts use of appropriated funds to necessary eligible expenditures incurred during the period beginning March 1, 2020, and ending on December 30, 2020. Provides for the funds to remain available until December 30, 2020, or until the later of June 30, 2022, or a date authorized by a congressional act allowing for the use of federal CARES Act funds beyond December 30, 2020, if the CARES Act is amended.

Changes the act's long title.

© 2020 School of Government The University of North Carolina at Chapel Hill

This work is copyrighted and subject to "fair use" as permitted by federal copyright law. No portion of this publication may be reproduced or transmitted in any form or by any means without the express written permission of the publisher. Distribution by third parties is prohibited. Prohibited distribution includes, but is not limited to, posting, e-mailing, faxing, archiving in a public database, installing on intranets or servers, and redistributing via a computer network or in printed form. Unauthorized use or reproduction may result in legal action against the unauthorized user.

Printer-friendly: Click to view